Nancy Vitale - 03 Jun 2025 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Director
Signature
/s/ Robin Swartz, as Attorney-in-Fact for Nancy Vitale
Issuer symbol
VYGR
Transactions as of
03 Jun 2025
Net transactions value
$0
Form type
4
Filing time
04 Jun 2025, 21:09:17 UTC
Previous filing
07 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vitale Nancy Director C/O VOYAGER THERAPEUTICS, INC., 75 HAYDEN AVENUE, LEXINGTON /s/ Robin Swartz, as Attorney-in-Fact for Nancy Vitale 04 Jun 2025 0001823262

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VYGR Stock Option (Right to Buy) Award $0 +24,000 $0.000000 24,000 03 Jun 2025 Common Stock 24,000 $3.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the "Vesting Commencement Date") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director.

Remarks:

Exhibit 24.1: Limited Power of Attorney